The Naval Medical Center San Diego (NMCSD) intends to award a sole source purchase order under the authority of FAR 13.106-1(b), due to only one source being available to meet the Government's needs, to the Medtronic, Inc., 710 Medtronic Pkwy, Minneapolis, MN 55440-5603.
The requirement is for Reveal LINQ System approved by FDA. The Reveal LINQ Insertable Cardiac Monitoring System may help the doctor diagnose and treat irregular heartbeats that may be related to unexplained fainting. It is designed for people who experience infrequent fainting symptoms. The Reveal LINQ ICM is the smallest heart monitor; automatically detects and records abnormal heart rhythms for up to 3 years; and safe for use in an MRI setting.
This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.
Capability statements are due by 4:00 PM Local Time, June 27, 2016. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: [email protected]